Dual Antiplatelet Therapy with 3rd Generation P2Y12 Inhibitors in STEMI Patients: Impact of Body Mass Index on Loading Dose–Response
Fernando Scudiero, Mario Enrico Canonico, Giuseppe D. Sanna, Filippo Dossi, Angelo Silverio, Gennaro Galasso, Giovanni Esposito, Italo Porto, Guido Parodi
Topics & Concepts
MedicineTicagrelorPrasugrelP2Y12Internal medicineClopidogrelBody mass indexPropensity score matchingAspirinCardiologyConfoundingAntiplatelet Therapy and Cardiovascular DiseasesPlatelet Disorders and TreatmentsAcute Myocardial Infarction Research